Stock listing

Diasorin S.p.a.

Selected listing: A0MTB2 · LS · EUR · DE

Diasorin S.p.a. (Lang & Schwarz: A0MTB2), Health Technology. Latest release May 19, 2026: DiaSorin S p A : Receives 510(K) Clearance for Fully Customizable…

A0MTB2:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A0MTB2
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Diasorin S.p.a.

The company specializes in diagnostic solutions, focusing on developing and manufacturing tests for various medical applications. Diasorin aims to enhance healthcare through innovative technologies and products in the diagnostics sector.

Latest news from Diasorin S.p.a.

DiaSorin S p A : Receives 510(K) Clearance for Fully Customizable LIAISON PLEX Gastrointestinal Flex Assay

May 19, 2026

DiaSorin S p A : Strengthens its Leadership of Immuno Division with the Appointment of Gabriele Allegri as President

May 4, 2026

DiaSorin S p A : Revenues and EBITDA growth in line with FY 2025 Guidance. Proposed ordinary dividend per share of €1.30, +8.3% vs 2024

March 20, 2026

DiaSorin S p A : signs strategic distribution agreement with McKesson Medical Surgical to expand access for the LIAISON NES molecular point‑of‑care platform

March 19, 2026

DiaSorin S p A : introduces next-generation LIAISON QuantiFERON-TB Gold Plus II assay for the U.S. in partnership with QIAGEN

February 24, 2026

All Diasorin S.p.a. news →

Research Diasorin S.p.a.

Diasorin S.p.a. company profile

View the public company page for Diasorin S.p.a. on 6ix.

Diasorin S.p.a. news

Read company news and market updates connected to Diasorin S.p.a..

Diasorin S.p.a. investor events

Find investor webinars, events, and replay context for Diasorin S.p.a..